Dalbavancin Outpatient Pilot

Clinical trial NCT03982030 · WITHDRAWN

Trial details

NCT number: NCT03982030
Sponsor: Wake Forest University Health Sciences
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Gram-Positive Bacterial Infections Soft Tissue Infections

Start date: 2023-04-01
Primary completion: 2025-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.